Recent research focusing on Semaglutide at a dosage of 20mg is shedding new light on its potential effects. Preliminary findings suggest that this higher dosage may enhance the drug's ability to manage blood sugar, potentially offering more significant outcomes for individuals with insulin resistance. Further investigation is underway to fully expl